News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TechnoVax Inc. Licenses Wyeth (WYE)'s Virus-Like Particle Vaccine Technology


12/11/2006 12:39:16 PM

TARRYTOWN, N.Y.--(BUSINESS WIRE)--TechnoVax Inc., a privately held developer of novel vaccine technologies announced that it has signed a license agreement with Wyeth (NYSE: WYE), to obtain rights to a fundamental patent application in the field of virus-like particle (VLP) technology. The agreement provides for an upfront payment, annual minimum royalty payments, milestone payments to Wyeth upon the achievement of certain development events, royalties on product sales, and an equity grant to Wyeth when TechnoVax completes an initial equity financing.

Read at BioSpace.com

comments powered by Disqus
   
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES